Market Research Report
Bio-Imaging - Global Market Outlook (2017-2026)
|Published by||Stratistics Market Research Consulting||Product code||791949|
|Published||Content info||166 Pages
Delivery time: 2-3 business days
|Bio-Imaging - Global Market Outlook (2017-2026)|
|Published: January 1, 2019||Content info: 166 Pages||
According to Stratistics MRC, the Global Bio-Imaging Market is accounted for $2.52 billion in 2017 and is expected to reach $10.98 billion by 2026 growing at a CAGR of 17.8% during the forecast period. An aging population, increasing number of diagnostic centers and radiopharmaceutical is expected to propel market demand. However, high-price linked with bio-imaging tools is a major factor hampering the growth of the market. Moreover, approval of biological imaging techniques in food, and agriculture industries for valuation of eminence and detecting defects in food items provides ample opportunities in the coming years.
Biological imaging may refer to any imaging technique in the field of healthcare and biomedical research. Bio-imaging is that twig of science that is concerned with efficient and structural images of human bodies. It uses various processes and techniques that replicate the snap of human tissues and anatomy at a molecular level. This technology can diagnose, treat and prevent diseases by using superior imaging techniques.
Based on Technology, molecular technology segment is anticipated to grow during the forecast period. The biological molecular imaging section focuses on recognition of disease-specific biomarkers development of new molecular imaging probes with cellular and molecular biology-oriented techniques and methods. On the basis of geography, the Asia Pacific region is witnessing lucrative expansion owing to the increasing number of hospitals. Emerging economies such as China and India are expected to be key potential markets for this technology owing to the growing demand for healthcare system over the forecast period.
Some of the key players profiled in the Bio-Imaging include Positron Corporation, Toshiba, Fujifilm Holdings, Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Digirad, FONAR Corporation, Lantheus Medical Imaging Inc, Covidien Pharmaceuticals, Mindray Medical International Limited, Psilos Group, Samsung Medison Co, Philips Healthcare, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare, GE Healthcare, Hologic Inc and Hitachi Medical Systems.
All the customers of this report will be entitled to receive one of the following free customization options: